OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Thrombocytopenia and splenic platelet-directed immune responses after IV ChAdOx1 nCov-19 administration
Leo Nicolai, Alexander Leunig, Kami Pekayvaz, et al.
Blood (2022) Vol. 140, Iss. 5, pp. 478-490
Open Access | Times Cited: 54

Showing 26-50 of 54 citing articles:

Thromboembolic Events in the Era of COVID‐19: A Detailed Narrative Review
Manal Mansour, Christophe El Rassi, Bshara Sleem, et al.
Canadian Journal of Infectious Diseases and Medical Microbiology (2025) Vol. 2025, Iss. 1
Open Access

Recent Advances in Immunothrombosis and Thromboinflammation
Rainer Kaiser, Christoph Gold, Konstantin Stark
Thrombosis and Haemostasis (2025)
Closed Access

Distinct platelet crosstalk with adaptive and innate immune cells after adenoviral and mRNA vaccination against SARS-CoV-2
Ludovica Lombardi, Francesca Maiorca, Ramona Marrapodi, et al.
Journal of Thrombosis and Haemostasis (2023) Vol. 21, Iss. 6, pp. 1636-1649
Open Access | Times Cited: 9

Adenoviral-vectored next-generation respiratory mucosal vaccines against COVID-19
Sam Afkhami, Alisha Kang, Vidthiya Jeyanathan, et al.
Current Opinion in Virology (2023) Vol. 61, pp. 101334-101334
Open Access | Times Cited: 9

Viral-vectored respiratory mucosal vaccine strategies
Mangalakumari Jeyanathan, Sam Afkhami, Alisha Kang, et al.
Current Opinion in Immunology (2023) Vol. 84, pp. 102370-102370
Closed Access | Times Cited: 8

Platelets interact with CD169+ macrophages and cDC1 and enhance liposome-induced CD8+ T cell responses
Joanna Grabowska, Valentine Léopold, Katarzyna Olesek, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6

Vaccine‐induced immune thrombotic thrombocytopenia (VITT) after SARS‐CoV‐2 vaccination: Two cases from Germany with unusual presentation
Rhea Edmonds, Linda Schönborn, Sunke Habben, et al.
Clinical Case Reports (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 4

Inactivated whole-virion SARS-CoV-2 vaccines and long-term clinical outcomes in patients with coronary atherosclerosis disease in China: a prospective cohort study
Huajie Xu, Jiaojiao Zheng, Xin Zhao, et al.
Cardiovascular Research (2023) Vol. 119, Iss. 6, pp. 1352-1360
Closed Access | Times Cited: 4

Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT)—Insights from Clinical Cases, In Vitro Studies and Murine Models
Venkata A. S. Dabbiru, Luisa Müller, Linda Schönborn, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 19, pp. 6126-6126
Open Access | Times Cited: 4

“Vaccine‐induced immune thrombotic thrombocytopenia (VITT)—Update on diagnosis and management considering different resources”: Comment
Maria Elena Paez Alacron, Andreas Greinacher
Journal of Thrombosis and Haemostasis (2022) Vol. 20, Iss. 11, pp. 2707-2708
Open Access | Times Cited: 6

Vaccine-Induced Immune Thrombotic Thrombocytopenia Two Years Later: Should It Still Be on the Scientific Agenda?
Eleonora Petito, Paolo Gresele
Thrombosis and Haemostasis (2023) Vol. 125, Iss. 02, pp. 097-107
Closed Access | Times Cited: 3

The immunology of PF4 polyanion interactions
Anh T. P. Ngo, Veronica Bochenek, Kandace Gollomp
Current Opinion in Hematology (2023) Vol. 30, Iss. 6, pp. 219-229
Closed Access | Times Cited: 3

COVID-19 vaccine–induced immune thrombotic thrombocytopenia: pathophysiology and diagnosis
Akbar Dorgalaleh, Ashkan Shabannezhad, Saeed Hassani
Annals of Hematology (2023)
Closed Access | Times Cited: 3

Immunvermittelte Sinus- und Hirnvenenthrombosen: VITT und prä-VITT als Modellerkrankung
Farid Salih, Linda Schönborn, Matthias Endres, et al.
Aktuelle Rheumatologie (2022) Vol. 47, Iss. 06, pp. 490-501
Open Access | Times Cited: 4

Selective Blood Cell Hitchhiking in Whole Blood with Ionic Liquid-Coated PLGA Nanoparticles to Redirect Biodistribution After Intravenous Injection
Christine M. Hamadani, Gaya S. Dasanayake, Claylee M. Chism, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 2

Antibodies against Platelet Glycoproteins in Clinically Suspected VITT Patients
Romy T. Meier, Leendert Porcelijn, Suzanne Hofstede‐van Egmond, et al.
Antibodies (2024) Vol. 13, Iss. 2, pp. 35-35
Open Access

Neurological Complications after COVID-19 Vaccination
K. Khalimova, Nilufar Rashidova, Javlon Salimjonov
Neuroscience and Behavioral Physiology (2024) Vol. 54, Iss. 4, pp. 540-546
Closed Access

Special Issue “Advances in Thrombocytopenia”
Lili Ji, Yunfeng Cheng
Journal of Clinical Medicine (2022) Vol. 11, Iss. 22, pp. 6679-6679
Open Access | Times Cited: 2

Platelets get particular
Lubica Rauova, Douglas B. Cines
Blood (2022) Vol. 140, Iss. 5, pp. 413-414
Open Access | Times Cited: 1

COVID vaccine-induced immune thrombotic thrombocytopenia: Rare but relevant
Andreas Greinacher
European Journal of Internal Medicine (2022) Vol. 105, pp. 20-22
Closed Access | Times Cited: 1

Scroll to top